Guggenheim analyst Michael Schmidt lowered the firm’s price target on SpringWorks Therapeutics (SWTX) to $78 from $80 and ...
As previously reported, Guggenheim analyst Joseph Osha initiated coverage of Primoris (PRIM) with a Buy rating and $102 price target The firm ...
Third-grade students at Guggenheim Elementary School were given a unique cultural experience on Jan. 3 when guest presenter ...
Agentforce was launched in September and already signed up 200 companies to deploy Agentforce as their smarter chatbot. Marc ...
As previously reported, Guggenheim analyst John DiFucci upgraded Workday (WDAY) to Neutral from Sell with no price target While the firm still ...
With its stunning Frank Lloyd Wright design, the Guggenheim Museum is a piece of art in itself. Inside these rounded walls, you’ll find floor upon floor of artistic treasures. The modern and ...
MongoDB stock was higher early Monday after analysts at Guggenheim upgraded their view on the company to a buy rating.
The exhibition spotlights a contradictory modern art movement that, though it celebrated technological advances, was rooted ...
Guggenheim has expanded its risk-management capabilities significantly in recent ‎‎years, though, and valuation-driven cutting of risk in 2018 and 2019—despite putting the strategy ...
Guggenheim New York is an icon of adventurous originality. Experience special exhibitions in our iconic, spiraling rotunda, plus highlights from our collection by Picasso, Degas, and Van Gogh.
Salesforce ended 2024 on a high note but fell on Monday after a Guggenheim analyst downgraded shares of the software company.